SUTRO BIOPHARMA, INC. Annual Operating Income (Loss) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Sutro Biopharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2023.
  • Sutro Biopharma, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$67.9M, a 54.3% decline year-over-year.
  • Sutro Biopharma, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$130M, a 28.4% increase year-over-year.
  • Sutro Biopharma, Inc. annual Operating Income (Loss) for 2023 was -$89.3M, a 30.8% increase from 2022.
  • Sutro Biopharma, Inc. annual Operating Income (Loss) for 2022 was -$129M, a 30.9% decline from 2021.
  • Sutro Biopharma, Inc. annual Operating Income (Loss) for 2021 was -$98.5M, a 38.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$89.3M +$39.7M +30.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-25
2022 -$129M -$30.4M -30.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-25
2021 -$98.5M -$27.5M -38.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-25
2020 -$71.1M -$15.6M -28.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-30
2019 -$55.5M -$18.2M -49% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 -$37.2M -$18M -93.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-18
2017 -$19.3M -$20.6M -1513% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-16
2016 $1.36M Jan 1, 2016 Dec 31, 2016 10-K 2019-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.